UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6851
Dare Bioscience
DARE
$21M
| $101K | ﹤0.01% |
32,393
+31,508
| +3,560% | +$109K |
|
6852
Garden Stage Ltd
GSIW
$23.5M
| $101K | ﹤0.01% |
758
+660
| +673% | +$130K |
|
|
DEVS
6853
DELISTED
DevvStream Corp
DEVS
| $101K | ﹤0.01% |
13,380
+13,376
| +334,400% | +$520K |
|
|
TONX
6854
TON Strategy Co
TONX
$169M
| $100K | ﹤0.01% |
15,358
+14,186
| +1,210% | +$125K |
|
6855
State Street Nuveen Municipal Bond ETF
MBND
$26.9M
| $100K | ﹤0.01% |
+3,650
| New | +$101K |
|
|
INZY
6856
DELISTED
Inozyme Pharma
INZY
| $100K | ﹤0.01% |
36,175
+10,411
| +40% | +$39.6K |
|
6857
YieldMax Innovation Option Income Strategy ETF
OARK
$32.9M
| $100K | ﹤0.01% |
1,971
+1,759
| +830% | +$93K |
|
6858
Swvl Holdings
SWVL
$13.7M
| $99.9K | ﹤0.01% |
15,657
+15,435
| +6,953% | +$74.5K |
|
6859
Lee Enterprises
LEE
$182M
| $99.8K | ﹤0.01% |
6,755
+6,417
| +1,899% | +$99.3K |
|
|
KZR
6860
DELISTED
Kezar Life Sciences
KZR
| $99.7K | ﹤0.01% |
14,840
+14,800
| +37,000% | +$110K |
|
|
ERH
6861
Allspring Utilities & High Income Fund
ERH
$103M
| $99.3K | ﹤0.01% |
9,262
-1,346
| -13% | -$14.7K |
|
|
EXEEL
6862
DELISTED
Expand Energy Corp Class C Warrants
EXEEL
| $99.2K | ﹤0.01% |
1,147
+750
| +189% | +$60K |
|
6863
Invesco S&P SmallCap Momentum ETF
XSMO
$3.1B
| $99.2K | ﹤0.01% |
1,500
-2,500
| -63% | -$172K |
|
6864
AirSculpt Technologies
AIRS
$353M
| $99.1K | ﹤0.01% |
19,100
+11,791
| +161% | +$72.4K |
|
6865
Flexible Solutions
FSI
$64.1M
| $98.9K | ﹤0.01% |
27,407
-18,389
| -40% | -$70.2K |
|
6866
Franklin FTSE Asia ex Japan ETF
FLAX
$57.2M
| $98.8K | ﹤0.01% |
4,350
+3,650
| +521% | +$87.4K |
|
6867
Karyopharm Therapeutics
KPTI
$48M
| $98.6K | ﹤0.01% |
9,719
+754
| +8% | +$9.12K |
|
6868
ActivePassive Core Bond ETF
APCB
$1.01B
| $98.4K | ﹤0.01% |
+3,394
| New | +$100K |
|
6869
ProShares UltraShort Russell2000
TWM
$41.3M
| $98.2K | ﹤0.01% |
2,210
-2,009
| -48% | -$86.2K |
|
|
PMBS
6870
PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund
PMBS
$1.39B
| $98.2K | ﹤0.01% |
2,052
+641
| +45% | +$31.2K |
|
6871
Fennec Pharmaceuticals
FENC
$402M
| $98.1K | ﹤0.01% |
15,522
+4,299
| +38% | +$22K |
|
6872
TBG Dividend Focus ETF
TBG
$264M
| $97.9K | ﹤0.01% |
+3,064
| New | +$100K |
|
6873
Conductor Global Equity Value ETF
CGV
$134M
| $97.3K | ﹤0.01% |
7,753
+7,531
| +3,392% | +$98.8K |
|
6874
Fusion Fuel Green
HTOO
$17.1M
| $97K | ﹤0.01% |
4,924
| – | – |
|
6875
Townsquare Media
TSQ
$118M
| $96.9K | ﹤0.01% |
10,664
+4,462
| +72% | +$44.7K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.